文献速递造血干细胞移植与细胞治疗白血病

激活自然杀伤细胞以预防造血干细胞移植后复发并诱导缓解的策略

Strategies to activate NK cells to prevent relapse and induce remission following hematopoietic stem cell transplantation.
PubMed 文献 · Blood · 2018-01-22

综述探讨异基因移植后自然杀伤(NK)细胞虽为首个重建的淋巴细胞但功能失调,调控该第一波淋巴细胞可能有助于降低减低强度预处理移植后40%的复发率。文章汇总KIR单倍型、HLA配体、巨细胞病毒驱动的适应性NK细胞及过继转移、白介素-15、CD16结合抗体、免疫衔接分子和检查点抑制剂等激活策略。

要点

  • 异基因移植后NK细胞为首个重建淋巴细胞但功能失调,调控此第一波细胞可能降低移植后40%复发率。
  • 供者具有KIR B单倍型且缺乏受者HLA-C表位,可对急性髓系白血病复发提供保护。
  • 巨细胞病毒感染可刺激并扩增表达NKG2C受体、效应功能增强的适应性NK细胞。

核心结论

  • 调控移植后第一波NK细胞可能有助于降低减低强度预处理移植后40%的复发率。
  • NK细胞过继转移联合白介素-15、CD16结合抗体、免疫衔接分子及检查点抑制剂等策略具有相当大的抗癌治疗潜力。

研究设计与样本

  • 综述,检索范围未报告。

主要发现

  • 异基因移植后NK细胞为首个重建的淋巴细胞,但功能失调。
  • 减低强度预处理移植后复发率为40%。
  • 抑制性KIR识别同源HLA I类配体负责NK细胞教育,使其对健康细胞耐受而对HLA I类表达降低的不健康细胞有反应。
  • 供者具有KIR B单倍型且缺乏受者HLA-C表位,可对急性髓系白血病复发提供保护。
  • 巨细胞病毒感染刺激并扩增表达NKG2C受体、效应功能增强的适应性NK细胞,其显示免疫记忆和类似CD8 T细胞的甲基化特征。

关键数值与推荐

  • KIR A与KIR B为功能不同的KIR单倍型组,KIR基因内容不同。
  • KIR编码于染色体19q。
  • 供者具有KIR B单倍型且缺乏受者HLA-C表位,与急性髓系白血病复发保护相关。
  • 适应性NK细胞表达NKG2C受体并显示增强的效应功能。

临床怎么用

  • NK细胞包括适应性NK细胞可联合或不联合白介素-15等促进NK细胞存活的药物进行过继转移。
  • NK细胞输注联合CD16结合抗体或免疫衔接分子可使NK细胞具有抗原特异性。
  • 上述策略与检查点抑制剂联合具有相当大的抗癌治疗潜力。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Natural killer (NK) cells are lymphocytes of innate immunity that respond to virus infected and tumor cells. After allogeneic transplantation, NK cells are the first reconstituting lymphocytes, but are dysfunctional. Manipulating this first wave of lymphocytes could be instrumental in reducing the 40% relapse rate following transplantation with reduced-intensity conditioning. NK cells express numerous activating and inhibitory receptors. Some recognize classical or nonclassical HLA class I ligands, others recognize class I-like ligands or unrelated ligands. Dominant in the NK-cell transplant literature are killer cell immunoglobulin-like receptors (KIRs), encoded on chromosome 19q. Inhibitory KIR recognition of the cognate HLA class I ligand is responsible for NK-cell education, which makes them tolerant of healthy cells, but responsive to unhealthy cells having reduced expression of HLA class I. KIR A and KIR B are functionally distinctive KIR haplotype groups that differ in KIR gene content. Allogeneic transplant donors having a KIR B haplotype and lacking a recipient HLA-C epitope provide protection against relapse from acute myeloid leukemia. Cytomegalovirus infection stimulates and expands a distinctive NK-cell population that expresses the NKG2C receptor and exhibits enhanced effector functions. These adaptive NK cells display immune memory and methylation signatures like CD8 T cells. As potential therapy, NK cells, including adaptive NK cells, can be adoptively transferred with, or without, agents such as interleukin-15 that promote NK-cell survival. Strategies combining NK-cell infusions with CD16-binding antibodies or immune engagers could make NK cells antigen specific. Together with checkpoint inhibitors, these approaches have considerable potential as anticancer therapies.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Cooley S, Parham P, Miller JS, et al. Strategies to activate NK cells to prevent relapse and induce remission following hematopoietic stem cell transplantation. Blood. 2018. PMID: 29358179. doi:10.1182/blood-2017-08-752170

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。